Twin Lakes Capital Management, LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1847794
REDWOOD SHORES, CA
Position in GILD
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$7,361,452
-$736,223 QoQ
Shares Held
58,267
+0.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
3.01%
of 13F equity value
Holder Rank
#495
of 2,266 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Twin Lakes Capital Management, LLC holds $10,825,505 across 8 Drug Manufacturers - General names. GILD ranks #1 (68.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
This page
|
58,267 | $7,361,452 | |
| 2 | JNJ |
Johnson & Johnson
|
6,478 | $1,645,217 | |
| 3 | NVS |
Novartis AG
|
3,830 | $600,237 | |
| 4 | LLY |
ELI LILLY & Co
|
325 | $389,814 | |
| 5 | PFE |
Pfizer Inc
|
15,868 | $382,101 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
4,781 | $275,481 | |
| 7 | MRK |
Merck & Co., Inc.
|
1,328 | $170,648 | |
| 8 | OGN |
Organon & Co.
|
41 | $555 |
All Filings in GILD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,361,452 | 58,267 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $8,097,675 | 58,102 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $7,211,465 | 58,754 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $6,517,809 | 58,719 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $6,688,565 | 60,328 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $7,004,917 | 62,516 | Shares | Sole | 2025-05-23 | |
| 2024-12-31 | $6,955,091 | 75,296 | Shares | Sole | 2025-02-19 | |
| 2024-09-30 | $6,277,100 | 74,870 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $5,228,768 | 76,210 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $5,590,733 | 76,324 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $6,133,348 | 75,711 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $5,892,607 | 78,631 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $6,013,155 | 78,022 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $6,423,869 | 77,424 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $6,599,375 | 76,871 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $4,713,979 | 76,414 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $13,157,394 | 221,123 | Shares | Sole | 2022-08-18 | |
| 2022-03-31 | $5,594,185 | 94,099 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $6,744,234 | 92,883 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $6,483,616 | 92,822 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $6,359,221 | 92,350 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $6,272,470 | 97,052 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $5,735,405 | 98,445 | Shares | Sole | 2021-02-26 | |
| No filing history on record for this holder in this stock. | ||||||